首页> 外文期刊>Immunology and Cell Biology >IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
【24h】

IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice

机译:IL-33抑制肿瘤小鼠粒细胞瘤细胞源性抑制细胞的分化和免疫抑制活性

获取原文
获取原文并翻译 | 示例
           

摘要

Myeloid-derived suppressor cells (MDSCs) contribute to tumor-mediated immune escape by suppressing antitumor immune responses. Interleukin-33 (IL-33) is capable of regulating various immune cell populations; however, the effects of IL-33 on the differentiation of MDSCs have not been well characterized. In this study, we evaluated the effects of IL-33 on MDSCs and found that IL-33 significantly reduced the differentiation of lineage-negative bone marrow progenitor cells into granulocytic MDSCs (G-MDSCs). IL-33-treated MDSCs exhibited diminished immunosuppressive capacity; reduced inhibition on T-cell proliferation and interferon-gamma production, and diminished production of reactive oxygen species. However, IL-33 treatment did not affect the frequency of monocytic MDSCs (M-MDSCs) or their production of nitric oxide and expression of arginase-1. Additionally, compared with control MDSCs, IL-33-treated MDSCs had reduced capacity to induce the differentiation or expansion of Treg cells. Moreover, in vivo IL-33 administration significantly decreased MDSCs and G-MDSCs accumulation in the spleen and tumor microenvironment. Also, despite increasing CD4(+) and CD8(+) T-cell infiltration, IL-33 administration markedly decreased Treg-cell population in tumor microenvironment. Taken together, our findings indicate that IL-33 reduces the frequency and immunosuppressive activity of G-MDSCs and ultimately the extent of tumor growth.
机译:霉菌衍生的抑制细胞(MDSCs)通过抑制抗肿瘤免疫应答来有助于肿瘤介导的免疫逃逸。白细胞介素-33(IL-33)能够调节各种免疫细胞群;然而,IL-33对MDSC的分化的影响并未得到很好的表征。在这项研究中,我们评估了IL-33对MDSC的影响,发现IL-33显着降低了谱系阴性骨髓祖细胞的分化为粒细胞MDSC(G-MDSC)。 IL-33处理的MDSCS表现出免疫抑制容量减少;降低对T细胞增殖和干扰素 - γ产生的抑制,并减少了活性氧的生产。然而,IL-33治疗不影响单核细胞MDSC(MDSC)的频率或其生产一氧化氮和氨基酶-1的表达。另外,与对照MDSC相比,IL-33处理的MDSCs减少了诱导Treg细胞的分化或扩增的能力。此外,在体内IL-33给药中,脾脏和肿瘤微环境中的MDSC和G-MDSCS积累显着降低。此外,尽管CD4(+)和CD8(+)T细胞浸润增加,但IL-33给药显着降低了肿瘤微环境中的Treg-细胞群。我们的研究结果表明,IL-33降低了G-MDSCS的频率和免疫抑制活性,并最终降低了肿瘤生长的程度。

著录项

  • 来源
    《Immunology and Cell Biology》 |2017年第1期|共9页
  • 作者单位

    Korea Univ Coll Life Sci &

    Biotechnol Div Life Sci Room 607 Hana Sci Bldg Anam Dong 5 Ga Seoul;

    Korea Univ Coll Life Sci &

    Biotechnol Div Life Sci Room 607 Hana Sci Bldg Anam Dong 5 Ga Seoul;

    Sookmyung Womens Univ Dept Life Sci Seoul South Korea;

    Korea Univ Coll Life Sci &

    Biotechnol Div Life Sci Room 607 Hana Sci Bldg Anam Dong 5 Ga Seoul;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学免疫学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号